Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 324
Immune Disorders Drugs 213
Biopharmaceuticals 186
Musculoskeletal Disorders Drugs 126
Drug Discovery 122
Genomics 120
Cardiovascular Drugs 107
Biotechnology 79
Clinical Trials 78
Biosimilars and Biosuperiors 77
Pharmaceuticals 75
Endocrine and Metabolic Disorders Drugs 72
Leukemia Drugs 71
Hematological Drugs 66
Infusions and Injectables 65
Dermatological Drugs 54
Women's Health 51
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 48
Allergy and Immunology 47
Needles and Syringes 47
Diagnostics 41
Skin Cancer Drugs 38
Drug Delivery 35
Psoriasis Drugs 35
Colon Cancer Drugs 34
Oncology 33
Gastrointestinal Drugs 32
Proteomics 29
Infectious Diseases Drugs 28
Immunosuppressive Drugs 27
Brain Cancer Drugs 25
Analgesics 25
Enzymes 25
Hematology 25
Pharmaceutical Manufacturing 25
Lung Cancer Drugs 23
Respiratory Drugs 23
Lymphoma Drugs 22
Kidney Cancer Drugs 18
Drugs by Therapeutic Area 15
Healthcare Services 15
Optical 15
Pancreatic Cancer Drugs 15
Therapeutic Area 14
Optical Disorders Drugs 14
Dermatology 13
Nanomedicine 13
Ovarian Cancer Drugs 12
Sexual and Reproductive Health Drugs 12
E-Healthcare 11
Generic Drugs 11
Urology and Nephrology 10
Prostate Cancer Drugs 10
Cervical Cancer Drugs 10
Other Healthcare Facilities 10
Liver Cancer Drugs 9
Breast Cancer Drugs 9
Cardiology 9
Pulmonary Medicine 8
In Vitro Diagnostics 8
Vaccines 8
Cancer Vaccines 8
Asthma Drugs 8
Biomarkers 7
Company Reports 6
Anti-Obesity Drugs 6
Gastroenterology 6
Diabetes Drugs 5
Biomaterials 5
Medical Devices 5
Molecular Diagnostics 5
Mental Disorders Drugs 5
Animal Pharmaceuticals 4
Pharmaceutical Intermediates 4
Cardiovascular Devices 4
Managed Care 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Laboratory Equipment 4
Pediatrics 4
Alzheimer's Disease Drugs 4
Bladder Cancer Drugs 3
Stem Cells 3
Over the Counter (OTC) Drugs 3
Acne Drugs 3
Schizophrenia Drugs 3
Neurology 2
Pharmacoeconomics 2
Fertility Services 2
Orthopedic Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Uterine Cancer Drugs 2
Clinical Skills 2
Patient Monitoring Equipment 1
Hepatology 1
Bioinformatics 1
Stents 1
Laboratory Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Nuclear Medicine and Radiopharmacology 1
Vitamins and Dietary Supplements 1
Clinical Therapies 1
Antibiotics 1
Palliative Care 1
Anatomy 1
Endocrinology 1
Maternal and Neonatal Care 1
Allergy Drugs 1
Urological Disorders Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,091 Results (Page 12 of 105)
- Relevance
  Sort by

Global Biosimilars Market 2020-2025

 Report
May 2021
358 Pages
Global

From

€1251EUR$1,375USD£1,073GBP

€2503EUR$2,750USD£2,146GBP

Filgrastim - Biosimilar Insight, 2022

 Report
January 2022
70 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Cancer Supportive Care Products Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

 Report
April 2024
105 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Nivolumab Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Injectable Hematology Growth Factors Report

 Report
January 2024
Global

From

€4414EUR$4,850USD£3,784GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Multiple Myeloma Market Report, Forecast by Drugs Types, Disease Types, End User, Countries and Company Analysis, 2024-2032

 Report
August 2024
200 Pages
Global

From

€2266EUR$2,490USD£1,943GBP

US Acute Myeloid Leukemia Market to 2028

 Report
October 2023
85 Pages
United States

From

€4414EUR$4,850USD£3,784GBP

TIL Therapies Market Industry Trends and Global Forecasts to 2035, by Target Indication, Key Players and Key Geographical Regions

 Report
February 2025
315 Pages
Global

From

€4368EUR$4,799USD£3,744GBP

Post Menopausal Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
149 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Schizophrenia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Europe Biosimilar Market Report 2025-2033

 Report
January 2025
126 Pages
Europe

From

€2729EUR$2,999USD£2,340GBP

Masked Antibodies & Cytokines as Prodrugs: A Landscape Analysis of Stakeholders, Technologies, Pipelines, Business and Financing from An Industry Perspective

 Report
October 2021
433 Pages
Global

From

€2250EUR$2,648USD£1,996GBP

Lung Cancer Therapeutics Market 2025-2033

 Report
March 2025
140 Pages
Global

From

€2729EUR$2,999USD£2,340GBP

Biosimilars Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Immunology Collaboration and Licensing Deals 2016-2025

 Report
April 2025
450 Pages
Global

From

€3636EUR$3,995USD£3,117GBP

Lung Cancer Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Biologic & Biosimilar RA Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Bioengineered Protein Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Europe Biosimilars Market Forecast to 2030 - Regional Analysis By Disease Indication, Route of Administration, Drug Class, Distribution Channel, and Region

 Report
August 2023
205 Pages
Europe

From

€3140EUR$3,450USD£2,692GBP

US Biosimilar Market: Insights & Forecast (2024-2028)

 Report
August 2024
72 Pages
United States

From

€569EUR$625USD£488GBP

€1138EUR$1,250USD£975GBP

2,091 Results (Page 12 of 105)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.